Dementia

The grounding supports dementia as a multifactorial condition with contributions from advanced age, genetic, socioeconomic, environmental, nutritional, and physical-activity-related determinants. It also links type 2 diabetes with increased risk of cognitive impairment and dementia. Cerebral amyloid-β aggregation is described as an early pathological event in Alzheimer disease that begins decades before dementia onset, but the grounding does not support this as a universal cause of dementia.

The literature grounding describes dementia in the context of progressive cognitive decline and age-related brain changes affecting brain size, vasculature, neurotransmitters, hormones, and cognition. It also notes that cerebral amyloid-β aggregation is an early pathological event in Alzheimer disease before dementia onset. Beyond this, the supplied material does not support a single unified biological mechanism for dementia.

Advanced age is identified as the main independent risk factor for cognitive impairment and dementia. Other supported risk factors or associated determinants include genetic, socioeconomic, and environmental factors, as well as nutrition and physical inactivity. Type 2 diabetes is also linked to increased risk of cognitive impairment and dementia.

The grounding supports nonpharmacologic management centered on prevention and supportive interventions, especially physical activity, aerobic exercise, healthy diet, and broader lifestyle modification. It also notes that there are no hitherto effective pharmaceutical therapies for age-associated cognitive impairment and dementia in the reviewed literature. Drug therapy is mentioned as a literature aspect, but the supplied abstracts do not support a specific standard drug-class treatment for dementia.